1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine

Metabolite details

Identifier

DYDDZDMJSQYFGN-OIVUZXIWSA-N

InChI Key

DYDDZDMJSQYFGN-OIVUZXIWSA-N

IUPAC name

(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate

Preferred name

1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine

INN name

—

Synonym

13.Phosphatidylcholine(16:1n7/20:4n6)

ChEBI

CHEBI:84816

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_Female_vs_Restricted_Female
• Control_vs_Palmitate